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Abstract
Background: Quality of life studies among injection drug users have primarily focused on health-
related measures. The chaotic life-style of many injection drug users (IDUs), however, extends far
beyond their health, and impacts upon social relationships, employment opportunities, housing, and
day to day survival. Most current quality of life instruments do not capture the realities of people
living with addictions. The Injection Drug Users' Quality of Life Scale (IDUQOL) was developed to
reflect the life areas of relevance to IDUs. The present study examined the content validity of the
IDUQOL using judgmental methods based on subject matter experts' (SMEs) ratings of various
elements of this measure (e.g., appropriateness of life areas or items, names and descriptions of life
areas, instructions for administration and scoring).
Methods: Six SMEs were provided with a copy of the IDUQOL and its administration and scoring
manual and a detailed content validation questionnaire. Two commonly used judgmental measures
of inter-rater agreement, the Content Validity Index (CVI) and the Average Deviation Mean Index
(ADM), were used to evaluate SMEs' agreement on ratings of IDUQOL elements.
Results: A total of 75 elements of the IDUQOL were examined. The CVI results showed that all
elements were endorsed by the required number of SMEs or more. The ADM results showed that
acceptable agreement (i.e., practical significance) was obtained for all elements but statistically
significant agreement was missed for nine elements. For these elements, SMEs' feedback was
examined for ways to improve the elements. Open-ended feedback also provided suggestions for
other revisions to the IDUQOL.
Conclusion: The results of the study provided strong evidence in support of the content validity
of the IDUQOL and direction for the revision of some IDUQOL elements.
Background
In the health and medical fields, quality of life (QoL) is
widely used to evaluate social and clinical interventions,
treatment side effects, and disease impact over time [1,2].
Most of these QoL instruments tend to focus on health-
related quality of life (HRQOL) or the functional effects of
respondents' perceived mental and physical health [3].
Gill and Feinstein [3], however, defined QoL as a reflec-
tion of respondents' perceptions and reactions to not only
their mental and physical health, but also to non-health
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related aspects of their lives (e.g., family, friends, work).
Thus, measurement of QoL needs to encompass more
than just the health-related aspects of respondents' lives.
Nearly all studies of QoL in injection drugs users (IDUs)
use measures of HRQOL [4-8]. Commonly used measures
of HRQOL with this population include the Opiate Treat-
ment Index [9], Nottingham Health Profile [10,11], the
Berlin Quality of Life Profile [12] and the MOS surveys
(including the SF-36 and the SF-12) [13-16]. Many studies
have shown that IDUs experience significantly lower
HRQOL relative to the general population [16-20] but, as
noted by Fernández Miranda [21], remarkably little pub-
lished research has examined QoL as an outcome variable
in the treatment of drug addiction [22,23].
Although previous research with IDUs and related popu-
lations (e.g., illicit drug users, HIV/AIDS) has considered
the effects of non-health related aspects of respondents'
lives on their HRQOL [4,7,15,24-28] or even on the initi-
ation or maintenance of drug use [29-35], rarely has pub-
lished research with IDUs used a broadly-defined QoL
measure (i.e., one that captures various social, psycholog-
ical, physical, geographic, and occupational domains of
QoL). Two exceptions would be Wasserman and col-
leagues [36], who examined the psychometric properties
of Lehman's [37] Quality of Life Interview – Brief Version
with IDUs, and Dunaj and Kovác [38], who compared
convicted drug addicts and controls on broadly-defined
QoL using the WHOQOL-BREF [39] and ComQol-A5
[40]. Dunaj and Kovác reported that addicts scored signif-
icantly lower than controls in their subjective ratings of
areas such as health, emotional well-being, safety, and
social standing.
Although broader measures of QoL are beginning to be
used with IDUs [36,38] and are certainly an improvement
over the use of strictly HRQOL measures, measures devel-
oped specifically for the IDU population and using a con-
text sensitive approach that considers the many life areas
deemed by IDUs as critical to their QoL, are still needed.
QoL, as defined by the World Health Organization Qual-
ity of Life (WHO-QOL) group, refers to "an individual's
perceptions of their position in life in the context of the
culture and value systems in which they live, and in rela-
tion to their goals, expectations, standards, and concerns"
(pp. 1–2) [41]. The item content and methods of admin-
istration for most available QoL instruments do not meas-
ure the QoL of drug users in a culturally-sensitive fashion
[42]. IDUs live in a distinct environment characterized by
a high prevalence of infectious disease, crime, violence,
and lack of stable housing. Many IDUs cannot depend on
basic necessities and experience considerable instability in
many aspects of their lives.
A recently developed broadly-defined QoL measure, the
Injection Drug User Quality of Life (IDUQOL) scale, was
designed to capture the health and non-health related
aspects of IDUs' lives that would be important compo-
nents of their quality of life, particularly given their indi-
vidual circumstances and environment [43,44]. This
measure has also been adapted for use in Spanish with
injection and non-injection drug users [45]. To use an
instrument with confidence, it is important that there be
evidence of validity – that is, the meaningfulness, useful-
ness, and appropriateness of an instrument for a given
population in a given context [46-48]. Previous research
has examined the factor structure, internal consistency,
and test-retest reliability of scores from the IDUQOL as
well as the criterion-related, convergent, and discriminant
validity of inferences made from the measure [44]. Con-
tent validity, a critical step in the test development and
validation process [49-51], refers to the degree to which
elements of an assessment tool are representative of the
construct of interest and appropriate for a given popula-
tion [52]. Importantly, the elements of interest in a con-
tent validation study are not just the content or items of
the measure, but all elements of the instrument including
the instructions, response format, and scoring procedures
[53].
The purpose of the present study was to examine the con-
tent validity of the IDUQOL using judgmental methods
based on subject matter experts' (SMEs) ratings of the
IDUQOL title, items, instructions, response format, scor-
ing procedures, and record form.
Methods
Participants
The sample consisted of a panel of six subject matter
experts (SMEs; 50% male), all of whom were researchers
working in the area of drug use in the United States or
Canada with an average of 10 years experience in the field.
Two SMEs were epidemiologists and four SMEs were phy-
sicians who also provided addiction and medical care to
drug users in their clinical practice. As noted by others
[54], there is no set number of SMEs required for content
validation studies. Typically, somewhere between three to
ten experts is recommended, although a minimum of five
SMEs is recommended to control for chance agreement;
furthermore, the larger the number of experts, the greater
the confidence in the ratings and the easier it is to detect
rater outliers [53,55].
Measures
The subject matter experts were provided with a copy of
the IDUQOL and its administration and scoring manual
and a detailed content validation questionnaire. Ethics
approval for this study was obtained from the UniversityHealth and Quality of Life Outcomes 2007, 5:46 http://www.hqlo.com/content/5/1/46
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of British Columbia and Providence Health Care Research
Ethics Boards.
Injection Drug User Quality of Life Scale (IDUQOL)
The original IDUQOL, which includes both health and
non-health related aspects of QoL [3] and is based on the
WHO-QOL group definition of QoL [41], consisted of 20
life areas. Several of these areas (e.g., Drugs, Drug Treat-
ment, Harm Reduction and Neighbourhood Safety) were
included in the measure precisely because of their partic-
ular relevance to the social and physical reality of IDUs as
confirmed by focus groups during the development phase
[43]. Each IDUQOL life area is represented on a 4 by 4
inch card, with the name of the area printed on the front
along with a simple picture. A description of the life area
is presented on the back (see Table 1 for a list of all 20 life
areas and descriptions). Graphic representation of the life
areas is intended to make the instrument more accessible
to individuals who have low literacy skills or do not speak
English as a first language. When administering the IDU-
QOL, the interviewer starts by showing the respondent
each of the 20 life area cards and describes the area. The
participant selects those areas that he/she deems impor-
tant to his/her quality of life and any remaining cards are
set aside. The cards representing important areas are laid
out and the participant is given three poker chips for each
card. The total number of chips can, therefore, range from
0 (no life areas are important) to 60 (all 20 life areas are
important). The participant then distributes the chips
across the cards to indicate the level of importance of each
life area, with more chips indicating greater importance.
Next, the participant provides a satisfaction rating for each
area, using a 6-point Likert-type scale anchored by 1 (very
dissatisfied) and 6 (very satisfied) and illustrated with six
stylised frowning and smiling faces.
When scoring the IDUQOL, the importance rating
(number of chips) of each area is divided by the total
number of chips used by that participant and then multi-
plied by the satisfaction rating for that area. This produces
an area score. Finally, all area scores are summed to obtain
an overall quality of life score ranging from 1 (very dissat-
isfied) to 6 (very satisfied).
IDUQOL content validation questionnaire
The questionnaire was divided into seven sections cover-
ing the clarity of the instrument title, ease of administra-
tion procedure instructions, clarity of the names and
descriptions of the 20 IDUQOL life areas, whether each of
the 20 IDUQOL life areas should be included in the meas-
ure (including whether any life areas need to be added,
revised, or deleted), ease of the response formats used for
each of importance and satisfaction ratings, clarity of scor-
ing procedure instructions, and the ease of use of the
record form. Experts were also given the opportunity to
provide open-ended commentary in each section. As rec-
ommended by Lynn [55], a four-point Likert type scale
was used in most cases. For questions involving clarity,
the following four response options were used: 0 = not at
all clear, 1 = somewhat clear, 2 = mostly clear, 3 = very
clear. For questions involving ease, the following four
response options were used: 0 = not at all easy to follow/
use, 1 = somewhat easy to follow/use, 2 = mostly easy to
follow/use, 3 = very easy to follow/use. For questions
involving inclusion of items, the following three response
options were used: 0 = no, 1 = unsure, 2 = yes. Two ques-
tions asked about how helpful the provided examples
were in the manual; for these, the following four response
options were used: 0 = not at all helpful, 1 = somewhat
helpful, 2 = mostly helpful, 3 = very helpful.
Procedures
The six SMEs were identified through the second author's
professional contacts with nationally and internationally
recognized experts in the area of substance abuse epidemi-
ology and treatment. They were sent a letter of invitation
and agreed to take part in the study. None of the SMEs
were associated with the development of the IDUQOL.
The SMEs were mailed a copy of the IDUQOL (which
included the 20 life area cards, poker chips, satisfaction
rating card, and record form), the administration and
scoring manual, and the IDUQOL content validation
questionnaire. As suggested by Grant and Davis [56],
SMEs were provided with the conceptual basis for the
IDUQOL via the brief introduction in the manual in
which the definition of QoL underlying this measure, the
target population, and how the measure is intended to be
used was provided. The SMEs completed the content vali-
dation questionnaire at their leisure and independently of
one another. All SMEs returned usable questionnaires.
Two commonly used judgmental measures of inter-rater
agreement, the Content Validity Index (CVI) [55,57] and
the Average Deviation Mean Index (ADM) [58-60], were
used to evaluate SMEs' agreement on ratings of the various
IDUQOL elements. The two measures provide very differ-
ent types of information, however, and should be viewed
as complementary. Generally, the CVI indicates the pro-
portion of SMEs that endorse an element as content valid
whereas the ADM indicates the degree of disagreement
among SMEs in the response option selected regardless of
whether they, as a group, endorsed an element or not.
Thus, one should first examine the CVI values to deter-
mine whether the SMEs endorsed an item or not and then
consider the level of agreement among the SMEs by exam-
ining the ADM.
The CVI can be computed at the individual item level (I-
CVI) and at the level of the overall scale or subscale (S-
CVI). I-CVI is computed as the proportion of SMEs thatHealth and Quality of Life Outcomes 2007, 5:46 http://www.hqlo.com/content/5/1/46
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endorse an item. Following standard procedures for four
response options [49,55], ratings of 2 or 3 were combined
and treated as endorsements by SMEs whereas ratings of 0
or 1 were combined and treated as non-endorsements in
the present study. When three response options were
used, a rating of 2 was treated as an endorsement by SMEs
whereas ratings of 0 or 1 were combined and treated as
non-endorsements. A minimum of five out of the six
SMEs (I-CVI ≥ .83) had to endorse an item to achieve sig-
nificant evidence (α = .05) of content validity for any
given item on the IDUQOL content validity questionnaire
and to provide confidence that agreement was not occur-
ring by chance alone [55]. Elements that were not
endorsed by a minimum of five SMEs were examined fur-
ther to determine if appropriate revisions could be made.
The S-CVI may be defined and computed a number of dif-
ferent ways, but Polit and Beck [49] recommend using the
average proportion of items endorsed by the SMEs (what
they refer to as S-CVI/Ave) and computing this as the aver-
age of the I-CVI values. This is the approach that will be
used in the present study in conjunction with Lynn's [55]
description of S-CVI as "the proportion of total items
judged content valid" (p. 384). For S-CVI/Ave, the mini-
mum acceptable value is recommended to be .90 [49].
The ADM Index measures dispersion of ratings about the
mean rating; thus, it is actually a measure of disagreement
so lower values indicate higher levels of agreement among
SMEs. An advantage of the ADM Index is that it provides a
measure of dispersion that is directly interpretable in
terms of the original rating scale units. The general cut-off
for determining acceptable ADM values is based on c/6,
with c referring to the number of response options [59].
Thus, using this guideline for practical significance,
acceptable ADM values are .50 or less for ratings with three
response options and .69 or less for ratings with four
response options. Critical values that can be used to eval-
uate whether an obtained ADM could have been achieved
by chance can also be computed. Critical values for ADM
at the 5% level of significance, taking into account the
number of SMEs and the number of response options in
the present study, would be .28 or less for three response
options and .44 or less for four response options [58].
ADM values that are equal to or below these critical values
are unlikely to have been obtained by chance. Elements
Table 1: Injection Drug User Quality of Life (IDUQOL) life area names and descriptions
Life Area Description
Being Useful e.g., volunteering, employment, participating in the community, helping 
others
Community Resources e.g., food bank, soup kitchen, shelters, outreach programs, social service 
agencies
Drugs drug use – e.g., alcohol, heroin, cocaine, crack
Drug Treatment e.g., detox, recovery house, residential treatment, methadone, 
abstinence
Education e.g., formal schooling, literacy programs
Family e.g., parents, children, siblings, foster families (not friends)
Feeling Good about Yourself e.g., self-esteem, self-worth
Friends anyone you consider a friend (but not family)
Harm Reduction access to, and experience with: e.g., methadone treatment, needle 
exchange, safe injection programs, prescription heroin
Health mental and physical health, including HIV, AIDS, Hepatitis C, disability, 
schizophrenia
Health Care access to, and experience with: physicians, nurses, hospitals, clinics, ER
Housing e.g., owning, renting, house, apartment, hotel room, shelters, homeless
Independence and Free Choice e.g., making your own decisions, autonomy, being able to do things on 
your own, having individual rights
Leisure Activities e.g., music, sports, movies, books, parties
Money e.g., income, welfare, cash flow, meeting your needs
Neighborhood Safety e.g., crime, violence, police harassment
Partner(s) e.g., spouse, common-law partner, same-sex partner, girlfriend or 
boyfriend (not casual partners)
Sex e.g., sexual intimacy, quantity or quality of sex, sex in exchange for 
money or drugs, sexual abuse
Spirituality e.g., religion, faith, belief in a higher being or spiritual world (or not)
Transportation e.g., car, taxi, public transportation, getting to places you need to goHealth and Quality of Life Outcomes 2007, 5:46 http://www.hqlo.com/content/5/1/46
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for which ADM values were neither practically nor statisti-
cally significant or were only practically significant were
examined further to determine if appropriate revisions
could be made.
Results
Content validity evidence for IDUQOL life areas
Table 2 presents the I-CVI and ADM results for each of the
20 IDUQOL life areas indicating whether (a) each life area
was appropriate for a QoL measure for IDUs, (b) the
name of the life area was clear, and (c) the description of
the life area was clear. I-CVI results showed that all indi-
vidual life areas, including the name used and the descrip-
tion provided, were endorsed by a minimum of five SMEs.
The ADM results provide additional information about the
extent to which the SMEs agreed on the exact rating (e.g.,
not at all clear, somewhat clear, mostly clear, very clear)
for each life area. In all cases, acceptable agreement (i.e.,
practical significance) was obtained. In terms of the
appropriateness of the life areas, each life area also
showed statistically significant agreement among the
SMEs. When considering whether the name of the life area
was clear, there were only two cases (i.e., Drugs, Inde-
pendence & Free Choice) in which agreement was accept-
able, but not statistically significant – meaning that
agreement could have occurred by chance. In the case of
Drugs, five SMEs rated this name as 'very clear' whereas
one SME thought it was only 'somewhat clear' because
drugs could be confused with medications. Independence
& Free Choice was rated as 'mostly clear' by half of the
SMEs and 'very clear' by the other half of SMEs with the
problem being different interpretations of the word "inde-
pendence". When considering whether the description of
the life area was clear, there were three cases (i.e., Being
Useful, Drugs, Feeling Good about Yourself) in which
agreement was acceptable, but not statistically significant.
The description for Being Useful was rated as 'somewhat
clear' by one SME, 'mostly clear' by one SME and 'very
clear' by four SMEs. Most SME comments were focused on
the visual depiction provided on the card and no sugges-
tions for changes or additions to the description were
offered. The description for Drugs (i.e., "drug use – e.g.,
alcohol, heroin, cocaine, crack") was rated as 'somewhat
clear' by one SME, 'mostly clear' by two SMEs and 'very
clear' by three SMEs. There were two concerns raised by
SMEs. The first and most prominent concern was that we
limited this life area to use of drugs; the second concern
was that we only listed four drugs. The description for
Feeling Good about Yourself (i.e., "e.g., self-esteem, self-
worth") was rated as 'mostly clear' by half of the SMEs and
'very clear' by the other half of the SMEs. No suggestions
were made for changes to the description.
SMEs were also asked if there were any life areas that they
would recommend deleting or adding to the IDUQOL.
No life areas were recommended for deletion from the
IDUQOL. The following additional life areas were sug-
gested: food, pets, personal safety, sense of future (e.g.,
hopefulness, aspirations), employment (as its own life
area separate from Being Useful), and pain.
Table 3 shows that the S-CVI/Ave for the element group-
ings of Appropriateness, Name clarity, and Description
clarity of the IDUQOL life areas ranged from .97 to .99,
which exceeded the minimum value of .90 and is also
strong evidence of content validity.
Content validity evidence for other IDUQOL elements
Table 3 also shows that the S-CVI/Ave for the element
groupings of Clarity of Title and Target Population, Ease
of Administration Procedure, Ease of Scoring Procedure,
and Helpfulness of Provided Examples ranged from .92 to
1.00. Only Ease of Response Formats produced a S-CVI/
Ave (.83) that was below the minimum recommended
value of .90, although both items were endorsed by five
out of six SMEs.
I-CVI and ADM results for other individual elements (e.g.,
title, administration instructions, scoring instructions,
record form) of the IDUQOL measure and manual are
presented in Table 4. I-CVI results showed that all individ-
ual elements were endorsed by a minimum of five SMEs.
The ADM results show that acceptable agreement (i.e.,
practical significance) was obtained in all cases, although
there were four cases in which agreement was not statisti-
cally significant (i.e., Clarity of Title, Response Format –
Chips, Response Format – Smiley Faces, Scoring Proce-
dure – Summed Score).
The name or title of the IDUQOL was rated as 'somewhat
clear' by one SME, 'mostly clear' by one SME and 'very
clear' by four SMEs, with no suggestions made for how to
make the title clearer. The Response Format – Chips was
rated as 'somewhat easy to use' by one SME, 'mostly easy
to use' by one SME, and 'very easy to use' by four SMEs.
Suggestions were made for simplifying the instructions
given to IDUs about how to use the poker chips to indi-
cate the importance of the different life areas. In addition,
it was suggested that poker chips might act as a trigger for
IDUs with gambling issues. The Response Format – Smi-
ley Faces was rated as 'somewhat easy to use' by one SME
and 'very easy to use' by five SMEs. It was suggested that
we consider using an odd-numbered Likert-type scale
(rather than our 6-point Likert-type scale) for the smiley
faces that would permit a neutral response. The Scoring
Procedure – Summed Score was rated as 'somewhat easy
to follow' by one SME, 'mostly easy to follow' by one SME,
and 'very easy to follow' by four SMEs. It was suggestedHealth and Quality of Life Outcomes 2007, 5:46 http://www.hqlo.com/content/5/1/46
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that we clarify the headings on the record form so they
would better match the terms used in the manual.
Suggested revisions to the IDUQOL based on SME 
feedback
Open-ended feedback and comments from the SMEs
resulted in several other suggestions for changes to the
IDUQOL measure, materials, and manual. These may be
grouped into three points. First, suggestions were made to
expand the descriptions for (a) Education, (b) Family, and
(c) Sex. Second, it was pointed out that we needed to show
greater diversity in our cards involving people – specifi-
cally Family and Friends. Third, we were advised to revise
the cards depicting (a) Being Useful, and (b) Independ-
ence and Free Choice to make them clearer.
Discussion
Test development and validation are ongoing processes
designed to ensure measures and the inferences made
from them remain appropriate, relevant, and useful for
Table 2: Item level CVI (I-CVI) and ADM index values for each of the 20 IDUQOL life areas
Appropriate?a Nameb Descriptionb
Life Area I-CVI ADM I-CVI ADM I-CVI ADM
Being Useful 1.00 .00 1.00 .44 0.83 .67
Community 
Resources
1.00 .00 1.00 .28 1.00 .28
Drugs 1.00 .00 0.83 .55 0.83 .67
Drug Treatment 0.83 .28 1.00 .00 1.00 .28
Education 0.83 .28 1.00 .00 1.00 .28
Family 1.00 .00 1.00 .00 1.00 .44
Feeling Good 
about Yourself
0.83 .28 1.00 .28 1.00 .50
Friends 1.00 .00 1.00 .00 1.00 .28
Harm Reduction 1.00 .00 1.00 .00 0.83 .33
Health 1.00 .00 1.00 .00 1.00 .28
Health Care 1.00 .00 1.00 .00 1.00 .28
Housing 1.00 .00 1.00 .00 1.00 .00
Independence and 
Free Choice
0.83 .28 1.00 .50 1.00 .00
Leisure Activities 1.00 .00 1.00 .00 1.00 .00
Money 1.00 .00 1.00 .00 1.00 .28
Neighborhood 
Safety
1.00 .00 1.00 .00 1.00 .44
Partner(s) 1.00 .00 1.00 .28 1.00 .00
Sex 1.00 .00 1.00 .00 1.00 .44
Spirituality 1.00 .00 1.00 .00 1.00 .00
Transportation 1.00 .00 1.00 .00 1.00 .00
a Ratings were made on a 3-point scale. b Ratings were made on a 4-point scale.
Note. I-CVI: 1.00 = endorsement by all six subject matter experts (SMEs); 0.83 = endorsement by five of six SMEs. ADM Index: with a 3-point scale, 
acceptable values are .50 or less and statistically significant values are .28 or less; with a 4-point scale, acceptable values are .69 or less and 
statistically significant values are .44 or less. Values that are acceptable, but not statistically significant, are bolded.
Table 3: Scale level CVI (S-CVI/Ave) for elements of the IDUQOL measure and manual
IDUQOL Element S-CVI/Ave
Appropriateness of IDUQOL Life Areas (20 items)a 0.97
Clarity of IDUQOL Life Area Names (20 items)b 0.99
Clarity of IDUQOL Life Area Descriptions (20 items)b 0.98
Clarity of Title and Target Population (2 items)b 0.92
Ease of Administration Procedure (4 items)b 1.00
Ease of Response Formats (2 items)b 0.83
Ease of Scoring Procedure (3 items)b 0.94
Helpfulness of Provided Examples (3 items)b 1.00
Ease of the Record Form to Use (1 item)b 1.00
a Ratings were made on a 3-point scale. b Ratings were made on a 4-point scale.
Note. Ease of Record Form result is the same as the individual level findings; this element is included here for completeness. For S-CVI/Ave, the 
minimum acceptable value is .90. A scale level ADM Index could not be applied here as it requires scales comprised of essentially parallel items.Health and Quality of Life Outcomes 2007, 5:46 http://www.hqlo.com/content/5/1/46
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the target population and context of use [47]. The IDU-
QOL was developed as a measure of broadly defined sub-
jective QoL that incorporates both health and non-health
related aspects of IDUs' lives. Administration of the IDU-
QOL was designed to be sensitive to the diversity of liter-
acy levels, English language skills, attention levels, and
cognitive abilities of the target population. An important
step in test development and validation is the evaluation
of content validity. The purpose of the present study was
to examine the content validity of various elements of the
IDUQOL measure and manual using SMEs and two com-
monly used judgmental methods (i.e., CVI and ADM). The
CVI indicates the proportion of SMEs that endorse an ele-
ment as content valid whereas the ADM indicates the
degree of disagreement among SMEs in the response
option selected. Overall, the results of this study provide
strong evidence for the content validity of the elements of
the IDUQOL measure and manual. Specifically, the I-CVI
results supported the content validity of each of the indi-
vidual elements. These elements include the appropriate-
ness, name, and description of each of the 20 life areas,
clarity of the name of the measure, clarity of the target
population, ease of each step of the administration proce-
dure, ease of each response format (i.e., chips and smiley
face scale), ease of each step of the scoring procedure,
helpfulness of each of the provided example boxes in the
manual, and ease of use of the IDUQOL record form.
The S-CVI/Ave results also supported the content validity
of all of the grouped elements of the IDUQOL measure
and manual (e.g., Appropriateness of Life Areas, Ease of
Administration Procedure), with the exception of Ease of
Response Formats. Two points are worth noting about the
Ease of Response Formats case. First, when examined indi-
vidually using I-CVI, each of the two items under Ease of
Response Formats was endorsed by five of the six SMEs,
supporting their content validity. In fact, the one SME
who supposedly did not endorse either of these items
actually circled both 'somewhat easy to use' and 'mostly
easy to use' (responses that fell into the 'not endorsed' and
'endorsed' categories, respectively) in each case and indi-
cated that the ease of each response format for the target
population was an empirical question that should be
piloted instead. Using a conservative approach, we treated
this SME's response as a non-endorsement, although it
could be argued to be more ambiguous. Second, it should
be noted that when there are only two or three items mak-
ing up a grouping of elements (as is the case for the two-
item Ease of Response Formats grouping), the minimum
acceptable level of .90 for S-CVI/Ave cannot be reached
unless all but one item in the grouping achieves endorse-
ment by all six of the SMEs. Taking each of these points
into account, we would argue that the content validity of
the response formats should not be discounted, but that
care should be taken to ensure, through further study or
Table 4: Item level CVI (I-CVI) and ADM index values for IDUQOL measure and manual elements
IDUQOL Content Validity Questionnaire Itema I-CVI ADM Index
Clarity of Title 0.83 .67
Clarity of Intended Population 1.00 .00
Administration Procedure – Introduction 1.00 .28
Administration Procedure – Respondent 
Selects Life Areas
1.00 .44
Administration Procedure – Respondent Rates 
Importance
1.00 .00
Administration Procedure – Respondent Rates 
Satisfaction
1.00 .00
Response Format – Easy for Respondent to 
Use Chips
0.83 .67
Response Format – Easy for Respondent to 
Use Smiley Faces
0.83 .67
Scoring Procedure – Relative Importance Score 1.00 .44
Scoring Procedure – Importance × Satisfaction 
Score
1.00 .44
Scoring Procedure – Obtain Summed Score 0.83 .67
Example – Relative Importance Score 1.00 .00
Example – Importance × Satisfaction Score 1.00 .00
Example – Completed Sample Record Form 1.00 .00
Ease of the Record Form to Use 1.00 .28
a Ratings were made on a 4-point scale.
Note. I-CVI: 1.00 = endorsement by all six subject matter experts (SMEs); 0.83 = endorsement by five of six SMEs. ADM Index: with a 4-point scale, 
acceptable values are .69 or less and statistically significant values are .44 or less. Values that are acceptable, but not statistically significant, are 
bolded.Health and Quality of Life Outcomes 2007, 5:46 http://www.hqlo.com/content/5/1/46
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pilot testing, that these response formats are appropriate
to the group of IDUs with whom a researcher or practi-
tioner wishes to use the IDUQOL. Based on interviews we
conducted with the experienced staff who administered
the IDUQOL to participants in another study [44,61], that
sample of IDUs did not have difficulty using either
response format, although some respondents expressed
the desire for a neutral response option on the Likert-type
smiley face satisfaction scale.
In terms of the ADM results, practical significance was
obtained for all 75 elements of the IDUQOL and manual,
indicating a high level of agreement among the SMEs in
their ratings. However, statistical significance was not
reached for the following nine elements: (a) names for the
Drugs and Independence & Free Choice life areas, (b)
descriptions for the Being Useful, Drugs, and Feeling
Good about Yourself life areas, and (c) clarity of title, ease
of response format – chips, ease of response format – smi-
ley faces, and ease of scoring procedure – summed score.
Thus, for these elements, it is possible that SME agreement
on the ratings may have occurred by chance alone.
Both the CVI and ADM results and the open-ended feed-
back from the SMEs were used to make seven main revi-
sions to IDUQOL elements. First, the names for the Drugs
and Independence & Free Choice life areas were changed
to Drugs & Alcohol and Free Choice, respectively. We also
decided to take one SME's suggestion to change the Edu-
cation life area to Education & Training.
Second, descriptions for the life areas of Drugs & Alcohol,
Education, Family, and Sex were expanded. The original
and revised descriptions for each of these life areas are
provided in Figure 1. The descriptions for some other life
areas (e.g., Being Useful, Feeling Good about Yourself)
remained unchanged because SMEs had only commented
on the visual image used or had not provided any sugges-
tions for changes.
Third, we added Sense of Future as a life area to the IDU-
QOL with the following description: "e.g., hopefulness,
aspirations, dreams, goals". The SMEs made several sug-
gestions for life areas that could be added to the IDUQOL
(i.e., food, pets, personal safety, sense of future, employ-
ment, pain). After considerable thought and given previ-
ous IDU focus group discussions about important life
areas, we ultimately decided to only add Sense of Future
as its own life area to the measure. However, we recognize
that other researchers and practitioners may want to con-
sider including these suggestions as additional life areas in
their own work. Three points about our decision are
worth noting: (a) following discussion, we decided that
'personal safety' was an implicit part of Neighborhood
Safety, (b) we decided to incorporate 'pain' under our
description of the Health life area, and (c) we resisted add-
ing employment as its own life area because IDUs in a
concurrent focus group study strongly opposed viewing
employment as separate from, or more important than,
other aspects of 'being useful in society'.
Fourth, we made revisions to the visual depictions for
Friends, Family, Being Useful, and Free Choice. Based on
SMEs' comments, we increased the diversity of people in
the cards for Friends and Family (see Figure 2). For the
Being Useful and Free Choice life areas, SMEs recom-
mended using different images to make these concepts
clearer to respondents. The old and new cards are shown
in Figure 3.
Fifth, we were particularly struck by one SME's suggestion
that the poker chips used in the response format for
importance ratings might act as a trigger for IDUs with
gambling issues and so we changed these to unmarked
chips. We also incorporated suggestions made by SMEs
for simplifying the instructions given to IDUs in the man-
ual about how to use the chips to indicate the importance
of the different life areas.
Sixth, we changed the Likert-type smiley face scale used to
rate satisfaction from a 6-point scale to a 7-point scale that
would permit a neutral response. This was based not only
on SMEs' suggestions but also on our own concurrent
experiences in administering the IDUQOL to IDUs
[44,61]. We found that it was particularly appropriate to
have a neutral option available when the respondent was
rating satisfaction with a life area that had not been rated
as particularly important.
Seventh, we revised the headings used in the IDUQOL
record form so they would better match the terms used in
the manual and would make obtaining the summed score
easier (see Figure 4.)
Given the strong support provided by this study for the
content validity of the IDUQOL and its manual, the revi-
sions made to improve them further, and previous
research supporting the validity of inferences made from
the IDUQOL [44,61], the IDUQOL is a viable instrument
for assessing broad-based QoL in IDUs and potentially in
non-injection drug users [45]. The majority of published
research in which QoL is examined with IDUs focuses on
HRQOL. Future research is needed that examines the
impact of drug use and various treatment options on QoL
using broadly defined subjective QoL measures such as
the IDUQOL. Future research on the IDUQOL needs to
further examine its appropriateness and usefulness with
non-injection drug users, its sensitivity to change, and its
relationship with other broad-based QoL measures such
as the Quality of Life Interview – Brief Version, which wasHealth and Quality of Life Outcomes 2007, 5:46 http://www.hqlo.com/content/5/1/46
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originally developed for use with the mentally ill, or the
Personal Wellbeing Index, which is the successor to the
ComQol-A5 and was developed for use with the general
population [62].
Conclusion
The results from the present study provided strong sup-
port for the content validity of the elements of the IDU-
QOL measure and manual. Further revisions were made
based on the CVI and ADM results as well as the open-
ended feedback from the SMEs. These revisions included
(a) revised names for three life areas (now Free Choice,
Drugs & Alcohol, and Education & Training), (b) an
expanded description for the Drugs & Alcohol, Education
& Training, Family, and Sex life areas, (c) the addition of
Sense of Future as a life area, (d) revisions to the visual
depictions for Family, Friends, Being Useful and Free
Choice, (e) the use of unmarked chips rather than poker
chips in the response format for importance ratings, (f)
the inclusion of a neutral point on the Likert-type scale of
smiley faces for rating satisfaction, and (g) revisions to the
headings used in the IDUQOL record form to make
obtaining the summed score clearer. These revisions to the
IDUQOL resulted in an instrument that is even easier for
Samples of original and revised IDUQOL card descriptions Figure 1
Samples of original and revised IDUQOL card descriptions.
Original card descriptions 
DRUGS – drug use – e.g., alcohol, heroin, cocaine, crack 
EDUCATION – e.g., formal schooling, literacy programs 
FAMILY – e.g., parents, children, siblings, foster families (not friends) 
SEX – e.g., sexual intimacy, quantity or quality of sex, sex in exchange for money or 
drugs, sexual abuse 
Revised card descriptions 
DRUGS & ALCOHOL – e.g., marijuana, speed, alcohol, heroin, cocaine, crack, etc. and 
includes selling, buying, and using 
EDUCATION & TRAINING – e.g., formal schooling, literacy programs, high school 
equivalency, life skills training, job training, certification, 
pre-employment programs, language courses (e.g., ESL) 
FAMILY – e.g., parents, children, siblings, foster families, grandparents, cousins, aunts 
and uncles (not friends) 
SEX – e.g., sexual intimacy, sex in exchange for money or drugs, being safe when 
having sex (use of condoms), birth control, sexual abuse Health and Quality of Life Outcomes 2007, 5:46 http://www.hqlo.com/content/5/1/46
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Original and revised cards to improve diversity of people Figure 2
Original and revised cards to improve diversity of people.
Original cards Revised cards
Original and revised cards to improve poor graphics on cards Figure 3
Original and revised cards to improve poor graphics on cards.
Original cards Revised cardsHealth and Quality of Life Outcomes 2007, 5:46 http://www.hqlo.com/content/5/1/46
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researchers, practitioners, and program evaluators to use
as a way of assessing and tracking changes in QoL over
time or as a result of interventions in IDUs.
List of abbreviations
ADM Average Deviation Mean Index
CVI Content Validity Index
HRQOL health-related quality of life
IDUs injection drug users
IDUQOL injection drug user quality of life scale
QoL quality of life
SMEs subject matter experts
Competing interests
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Original and revised IDUQOL record form headings Figure 4
Original and revised IDUQOL record form headings.
IDUQOL record form   (original) 
TOTAL NUMBER OF CHIPS USED (TN): _______ 
LIFE AREA WEIGHTING RATING SCORE
BEING USEFUL  _____ chips y TN = _______  x ______  = _______ 
COMMUNITY









IDUQOL record form   (revised) 










BEING USEFUL  _____ chips y TN = _______  x ______  = _______ 
COMMUNITY
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